Jutras Gabrielle, Huard Genevieve, Bilodeau Marc, Bissonnette Julien, Castel Helene, Giard Jeanne-Marie, Hercun Julian, Vincent Catherine, Willems Bernard, Willems Philippe, Lai Jennifer C
Department of Hepatology, Division of Medicine, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada.
Division of Gastroenterology and Hepatology, Department of Medicine, University of California - San Francisco, San Francisco, California, United States.
Can Liver J. 2024 Aug 28;7(3):345-351. doi: 10.3138/canlivj-2024-0006. eCollection 2024 Aug.
The surge of end-stage liver disease among older individuals challenges traditional age-based criteria for liver transplantation (LT), historically capped at 65 years. Our Canadian center shifted away from using chronologic age as an absolute refusal criterion since 2019, enabling those aged 65 years and older to seek LT. This study aimed to investigate temporal trends in the transplant care cascade for patients aged 65 and older at our center, pre- and post-clinical shift.
A retrospective study in a single Canadian transplant center reviewed LT referrals between 2015 and 2023, analyzing proportions of patients aged 65 and above at each stage. Specific intervals, 2015-2018 and 2019-2023, were defined for pre- and post-comparisons.
Among the 1,007 LT referrals, 11% (n = 110) were patients aged ≥65 years, with 74% ( = 81) of them being referred after 2019. From 2015 to 2023, older patient proportions increased at all stages of the transplant care cascade: referrals (7.4% to 12.6%), evaluations (7.6% to 11.4%), waitlisting (5.6% to 15.4%), and transplantations (5.8% to 17.5%). Post-clinical shift, the proportion of older patients referred nearly doubled (7.5% vs 13.7%; < 0.05), with a similar increase in transplants (5.7% vs. 11.5%; < 0.05).
Removing the age cap increased older patient engagement in the LT care cascade. This emphasizes the crucial role of actively promoting awareness of evolving LT eligibility criteria. Concerted efforts should focus on improving transplantation accessibility in older patients, ensuring age alone does not impede the process.
老年人群终末期肝病的激增对传统的基于年龄的肝移植(LT)标准提出了挑战,传统标准以往将年龄上限设定为65岁。自2019年以来,我们加拿大的中心不再将实际年龄作为绝对的拒绝标准,使得65岁及以上的人群能够寻求肝移植。本研究旨在调查我们中心临床转变前后65岁及以上患者移植护理流程中的时间趋势。
在加拿大一个单一的移植中心进行的一项回顾性研究,回顾了2015年至2023年期间的肝移植转诊情况,分析了每个阶段65岁及以上患者的比例。定义了特定时间段,即2015 - 2018年和2019 - 2023年,用于前后对比。
在1007例肝移植转诊病例中,11%(n = 110)为65岁及以上患者,其中74%(n = 81)是在2019年之后转诊的。从2015年到2023年,老年患者在移植护理流程的各个阶段的比例均有所增加:转诊(从7.4%增至12.6%)、评估(从7.6%增至11.4%)、列入等待名单(从5.6%增至15.4%)以及移植(从5.8%增至17.5%)。临床转变后,转诊的老年患者比例几乎翻倍(7.5%对13.7%;P < 0.05),移植患者比例也有类似增加(5.7%对11.5%;P < 0.05)。
取消年龄上限增加了老年患者参与肝移植护理流程的比例。这强调了积极宣传不断变化的肝移植资格标准的关键作用。应共同努力,专注于提高老年患者的移植可及性,确保仅年龄因素不会阻碍这一过程。